Alzheimer's Disease: Medical Treatments
Commons · Question 26382 · Tabled 24 Jan 2025 · Department of Health and Social Care · Official record
Answered 30 Jan 2025
Question
Asked by Freddie van Mierlo
To ask the Secretary of State for Health and Social Care, if he will have discussions with (a) Eisai Co., Ltd and Biogen Inc. and (b) Eli Lilly and Company on the production of disease-modifying treatments for Alzheimer's disease in the UK.
Answer
Answered by Andrew Gwynne, 30 Jan 2025
The Government deeply values its relationships with life science companies and is committed to getting treatments to National Health Service patients through our 10 Year Plan for the NHS. This will include a plan for procurement, giving a clearer route to...